REQUEST A DEMO
Total
USD $0.00
Search more companies

Integrar Soluciones Farmaceuticas S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Integrar Soluciones Farmaceuticas S.A.S Profile Updated: September 06, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Integrar Soluciones Farmaceuticas S.A.S is an enterprise located in Colombia, with the main office in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on June 02, 2015. Integrar Soluciones Farmaceuticas S.A.S currently employs 2 (2023) people. The company’s latest financial report indicates a net sales revenue drop of 71.34% in 2022. There was a total negative growth of 36.9% in Integrar Soluciones Farmaceuticas S.A.S’s total assets over the same period. In 2022, Integrar Soluciones Farmaceuticas S.A.S’s net profit margin increased by 2.5%.

Headquarters
Cl 22 20 60
Bucaramanga; Santander;

Contact Details: Purchase the Integrar Soluciones Farmaceuticas S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Integrar Soluciones Farmaceuticas S.A.S report to view the information.
Outstanding Shares:
Purchase the Integrar Soluciones Farmaceuticas S.A.S report to view the information.
Incorporation Date:
June 02, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Integrar Soluciones Farmaceuticas S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-71.34%
Total operating revenue
-71.34%
Operating profit (EBIT)
-87.17%
Net Profit (Loss) for the Period
683.71%
Total assets
-36.9%
Total equity
0.09%
Operating Profit Margin (ROS)
-1.38%
Net Profit Margin
2.5%
Return on Equity (ROE)
0.08%
Debt to Equity Ratio
-21.04%
Quick Ratio
143.59%
Cash Ratio
1.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?